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        The engagement of the T cell receptor with an-
tigen can lead to an immune response, tolerance, 
or homeostatic proliferation, depending on the 
properties of the antigen and the context in which 
it is encountered (  1  ). The outcome of a T cell re-
sponse to antigen stimulation is regulated by the 
interplay and complex interaction of positive 
(stimulatory) and negative (inhibitory) pathways. 
In optimal immune responses, antigen and co-
stimulatory molecules from activated antigen-
presenting cells induce strong mitogenic signals in 
naive T cells, leading to proliferation and diff  eren-
tiation of eff  ector T cells. However, under toler-
ant or homeostatic conditions, such as the lack of 
costimulatory signals or self-antigen stimulation, 
T cells either do not respond or undergo homeo-
static proliferation (  2, 3, 4, 5, 6  ). The molecular 
pathways controlling the diff  erent responses after 
TCR engagement are largely unknown. 
  Recently, we and others have found that 
Egr-2 is induced in tolerant T cells in response 
to antigen stimulation in vivo or TCR ligation 
in vitro (  7, 8, 9  ). Egr-2 is a member of a family 
of zinc fi  nger proteins, which consists of four 
members, Egr-1, -2, -3, and -4, and has been 
found to play a critical role in hindbrain develop-
ment and myelination of the peripheral nervous 
system (  10, 11  ). Together with Egr-1 and -3, 
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  Maintaining tolerance of T cells to self-antigens is essential to avoid autoimmune disease. 
How self-reactive T cells are kept functionally inactive is, however, unknown. In this study, 
we show that early growth response gene 2 (Egr-2), a zinc-fi  nger transcription factor, is 
expressed in CD44  high   T cells and controls their proliferation and activation. In the absence 
of Egr-2, CD44  high  , but not CD44  low   T cells, are hyperreactive and hyperproliferative in vivo. 
The accumulation of activated CD4  +  CD44  high   T cells leads to the development of a late 
onset lupuslike autoimmune disease characterized by the accumulation of interferon (IFN)-     
and interleukin (IL)-17  –  producing CD4  +   T cells, loss of tolerance to nuclear antigens, 
massive infi  ltration of T cells into multiple organs and glomerulonephritis. We found that 
the expression of cyclin-dependent kinase inhibitor p21cip1 was impaired in Egr-2  –  defi  -
cient T cells, whereas the expression of IFN-     and IL-17 in response to T cell receptor 
ligation was signifi  cantly increased, suggesting that Egr-2 activates the expression of genes 
involved in the negative regulation of T cell proliferation and infl  ammation. These results 
demonstrate that Egr-2 is an intrinsic regulator of effector T cells and controls the expan-
sion of self-reactive T cells and development of autoimmune disease. 
© 2008 Zhu et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the fi  rst six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons
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exposure, Egr-2  –  defi  cient T cells started to proliferate much 
faster than T cells from Egr-2-fl  ox/fl  ox mice (  Fig. 1 C  ). To ex-
clude possible eff  ects of the Cre transgene on T cell activation, 
T cells from hCD2 promoter-cre transgenic mice were also 
used for stimulation and showed the same responses as T cells 
from Egr-2-fl  ox/fl  ox mice (unpublished data), which is consis-
tent with previous reports (  13  ). Thus, Egr-2-fl  ox/fl  ox mice were 
used as a WT control. 
Egr-2 is expressed in thymocytes (  12  ) and in mature T cells 
upon TCR stimulation (  7, 8, 9  ). RNA interference (RNAi)  –
  mediated knockdown of Egr-2 in an established T cell line 
rendered the cells less susceptible to anergy induction (  7  ), 
whereas overexpression of Egr-2 reduced T cell activation 
in vitro (  7, 8  ) indicating that Egr-2 regulates genes involved 
in the suppression of T cell activation. However, the function 
of Egr-2 in T cells in vivo has not been studied, as Egr-2 KO 
mice die perinatally because of defects in hindbrain develop-
ment (  11  ). 
  In this study, we demonstrate that Egr-2 is expressed in 
  eff  ector phenotype T cells in the absence of obvious antigen 
stimulation in vivo. To assess the function of Egr-2 in T cells 
in vivo, we established Egr-2 conditional KOs (Egr-2 cKO), in 
which the Egr-2 gene was deleted specifi  cally in CD2  +   lym-
phocytes. The Egr-2  –  defi  cient T cells did not show altered pri-
mary activation, but were hyperproliferative in response to 
prolonged stimulation and exhibited a Th1 and Th17 bias lead-
ing to the development of a lupuslike syndrome in older mice. 
Defective expression of p21cip1 was detected in CD44  high   T 
cells from Egr-2 cKO mice, and Egr-2 was found to interact 
directly with the promoter of p21cip1 in vivo. In addition, 
IFN-      and IL-17 were highly induced in Egr-2  –  defi  cient T 
cells, and accumulation of IFN-       –   and IL-17  –  producing cells 
was associated with massive infi  ltration of T cells in multiple or-
gans. Our results demonstrate that Egr-2 is important for con-
trolling the self-tolerance of T cells and preventing autoimmunity 
through activation of negative regulators of cell proliferation 
and by controlling proinfl  ammatory cytokine expression. 
    RESULTS   
  Egr-2 negatively regulates the proliferation of activated 
T cells, but not naive T cells 
  In previous studies, we and others found that Egr-2 can be in-
duced in tolerant T cells (  7, 8, 9  ). To study the function of 
Egr-2 in T cells in vivo, we established Egr-2 cKO by crossing 
hCD2 promoter-cre transgenic mice (  13  ) with Egr-2-fl  ox/
fl  ox mice (  14  ). Egr-2 WT alleles, fl  oxed alleles, and the pres-
ence of the hCD2-cre transgene were determined by PCR 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20080187/DC1). Egr-2 was completely deleted from T 
cells in Egr-2 cKO mice (  Fig. 1 A  ).   However, expression 
of Egr-2 was still detected in B cells from Egr-2 cKO mice 
(Fig. S1), which is consistent with the weak activity of the 
CD2 promoter in B cells (  13  ). 
  The deletion of Egr-2 did not alter the development of the 
major thymocyte subsets, regulatory T cells, and major sub-
groups of peripheral T and B cells (Figs. S2 and S3, available at 
http://www.jem.org/cgi/content/full/jem.20080187/DC1). 
  In contrast to the suppressive role of Egr-2 discovered by 
Egr-2 knockdown in a T cell line (  7  ), the activation of Egr-2 
cKO T cells in response to primary TCR stimulation was not 
altered as indicated by normal levels of ERK activation and pro-
liferation (  Fig. 1 B   and Fig. S4, available at http://www.jem
.org/cgi/content/full/jem.20080187/DC1). However, after 
primary stimulation, under the condition of sustained IL-2 
    Figure 1.         Enhanced proliferative responses of Egr-2  –  defi  cient T 
cells to sustained IL-2 stimulation.  hCD2-Cre/Egr-2  fl  oxed mice were 
identifi  ed by PCR with primer pairs specifi  c for iCre, WT Egr-2, and fl  oxed 
Egr-2 (Fig. S1). (A) The expression of Egr-2 in T cells from spleens of Egr-2 
cKO and WT mice before and after TCR ligation in vitro was examined by 
real-time RT-PCR and immunoblotting. The relative expression of Egr-2 
mRNA was measured after normalizing against      -actin. (B) Proliferation 
of CD4  +   T cells from spleens of Egr-2 cKO and WT mice was analyzed in 
response to anti-CD3/CD28  –  coated beads or uncoated beads as a control. 
(C) CD4  +   T cells were fi  rst stimulated for 48 h with anti-CD3 (1  °  ), and then 
expanded in 100 U/ml IL-2 for 3 d. The cells were then recounted and 
restimulated with IL-2 (2  °  ) at different concentrations as indicated. The 
data are representative of three to fi   ve  experiments.   JEM VOL. 205, September 29, 2008 
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of CD44  low   T cells incorporated BrdU, and the proportion of 
BrdU  +  CD44  low   T cells was similar in Egr-2 cKO and WT mice 
(  Fig. 3 A  ). One possible explanation for the hyperproliferation 
of CD44  high   cells is that naive CD44  low   T cells have impaired 
survival in the absence of Egr-2, and that the resulting lympho-
penia induces hyperproliferation of CD44  high   T cells. To ex-
clude this possibility, CD4  +   or CD8  +   T cells from 7-mo-old 
mice were labeled with CFSE and adoptively transferred into 
WT mice. Consistent with the increase of CD44  high   T cells in 
vivo, CD44  high   T cells from Egr-2 cKO mice proliferated more 
than CD44  high   cells from WT mice (  Fig. 3 B  ), indicating that 
hyperproliferation of CD44  high   T cells from Egr-2 cKO mice is 
driven by an intrinsic mechanism. 
  Consistent with the hyperproliferation of CD4  +  CD44  high   
T cells, by 15 mo of age, most of the Egr-2 cKO mice devel-
oped a spontaneous lymphoproliferative disorder manifesting 
as splenomegaly, with a spleen size two to fi  ve times larger 
than that of WT mice (  Fig. 4 A  ).   The T cell population in 
  The enhanced proliferation of T cells from Egr-2 cKO 
mice did not result from alteration of IL-2 signaling, as indi-
cated by a normal level of STAT5 activation in Egr-2  –  defi  -
cient T cells in response to TCR ligation (Fig. S4). These 
results suggest that Egr-2 controls the turnover of eff  ector T 
cells, rather than primary T cell activation. 
  Egr-2 has been found to induce expression of FasL in ac-
tivated T cells (  15, 16  ). However, we could not detect altera-
tions in FasL expression and apoptosis in Egr-2  –  defi  cient T 
cells before or after TCR ligation (Fig. S5, available at http://
www.jem.org/cgi/content/full/jem.20080187/DC1). Col-
lectively, these data suggest that Egr-2 does not aff  ect TCR 
signaling or apoptosis induction, but instead controls the sub-
sequent expansion of activated T cells. 
  Egr-2 is expressed in CD44  high   T cells and is required for 
controlling the proliferation and activation of T cells in vivo 
  The hyperproliferation of Egr-2  –  defi  cient T cells in response to 
sustained, but not primary, stimulation suggests that Egr-2 defi  -
ciency may have more profound eff  ects on T cells that have 
diff  erentiated to an eff  ector phenotype, rather than naive T cells 
in vivo. In the absence of antigen immunization, CD44  high   ef-
fector phenotype T cells are predominantly the result of expo-
sure to environmental antigen, such as gut fl  ora, or to certain 
self-antigens (  2  ). Therefore, the responses of CD44  high   T cells 
have to be controlled to prevent the development of auto-
immune or hypersensitivity reactions (  1, 3  –  6  ). To investigate 
Egr-2 expression in CD44  high   and CD44  low   T cells, 
CD4  +  CD25        CD44  high   and CD4  +  CD25        CD44  low   T cells were 
isolated from spleens of WT mice by FACS. Egr-2 transcripts 
were highly expressed in CD4  +  CD44  high   T cells in contrast to 
the minimal expression in the CD4  +  CD44  low   population (  Fig. 
2 A  ).   Furthermore, Egr-2 protein was only detected in 
CD4  +  CD44  high   T cells (  Fig. 2 A  ). These results demonstrate 
that Egr-2 is expressed in eff  ector phenotype T cells in vivo. To 
investigate the eff  ect of Egr-2 defi  ciency on CD44  high   T cells, 
we examined their population at 3, 8, and 15 mo of age and 
their proliferative potential in WT and Egr-2 cKO mice. The 
percentage of CD44  high   CD62L  low   cells, which is character-
istic of eff  ector phenotype T cells, was normal at 3 mo, but 
increased at 8 mo in Egr-2 cKO mice compared with age-
matched WT mice (  Fig. 2 B  ). At 15 mo of age, all of the CD4  +   
T cells from spleens of Egr-2 cKO mice were CD44  high   and 
CD62L  low   in contrast to 21% of CD4  +   T cells in WT mice (  Fig. 
2 B  ). In contrast to the dramatic accumulation of CD44  high   T 
cells in Egr-2 cKO mice, B cells, NK cells, and macrophages 
were similar in both mouse types (Fig. S6, available at http://
www.jem.org/cgi/content/full/jem.20080187/DC1). To as-
sess the proliferative potential of these cells in vivo in the 
absence of experimental immunization, 8-mo-old mice were 
fed BrdU for 9 d, and then splenic T cells were analyzed for 
BrdU incorporation. 29.5% of CD8  +  CD44  high   and 21.5% of 
CD4  +  CD44  high   T cells from Egr-2 cKO mice had incorporated 
BrdU (  Fig. 3 A  ).   In contrast, the percentage of CD8  +  CD44  high   
and CD4  +  CD44  high   cells that had incorporated BrdU from WT 
mice was 14.1 and 12.1%, respectively (  Fig. 3 A  ). Less than 5% 
    Figure 2.         Egr-2 expression and CD44  high   T cells in vivo.  
(A) CD4  + CD25      CD44 low   and  CD4 + CD25      CD44 high   T cells were sorted 
from splenocytes of WT mice at 8 mo of age by FACS. The expression 
of Egr-2 in these two populations was examined by real-time RT-PCR 
and immunoblotting. The relative expression of Egr-2 mRNA was nor-
malized to      -actin mRNA. The results are representative of three ex-
periments. (B) Splenocytes from Egr-2 cKO and WT mice of different 
ages were stained for CD4, CD44, and CD62L. Cells were gated on the 
CD4  +   population.   2298 EGR-2 CONTROLS THE SELF-TOLERANCE OF T CELLS   | Zhu et al. 
the spleens of aged Egr-2 cKO mice was signifi  cantly in-
creased compared with age-matched WT mice (  Fig. 4 A  ). 
  In addition to the increase in T cell numbers, most CD4  +   
and nearly half of CD8  +   cells from Egr-2 cKO mice expressed 
CD25, CD44, and CD69, whereas   <  20% of CD4  +   or CD8  +   
cells from WT mice did (  Fig. 4 B  ), suggesting that the T cells 
in aged Egr-2 cKO mice are predominately eff  ector pheno-
type cells. These results demonstrate that loss of Egr-2 leads 
to the hyperproliferation and accumulation of activated CD-
44  high   T cells in vivo, indicating an intrinsic proliferative dis-
order of eff  ector T cells. 
  Development of lupuslike autoimmune disease in Egr-2 
cKO mice 
  We have now provided evidence that Egr-2 plays a central 
role in the control of eff  ector T cell proliferation and activa-
tion in vivo. The absence of Egr-2 resulted in hyperprolifera-
tion and accumulation of activated CD44  high   T cells, suggesting 
that Egr-2 cKO mice may be more susceptible to autoim-
mune disease. However, we did not observe any early onset 
autoimmunity such as diabetes or infl  ammatory bowel disease 
in Egr-2 cKO mice younger than 10 mo of age. However, af-
ter 1 yr, Egr-2 cKO mice started to show hair loss and became 
less active. By 15 mo of age, more than half of the Egr-2 cKO 
mice had died (12 out of 20 mice), whereas no death was ob-
served in age-matched WT mice. In contrast to age-matched 
WT mice, the majority of the surviving Egr-2 cKO mice 
exhibited features of systemic lupuslike autoimmune disease. 
The mice displayed hair loss and skin lesions and an accumula-
tion of infl  ammatory mononuclear cells in various tissues (  Fig. 
5, A and B  ).   Importantly, the majority of the infi  ltrated mono-
nuclear cells were T cells with a smaller proportion of B cells 
(  Fig. 5 C  ). After 12 mo, Egr-2 cKO mice showed signs of 
severe glomerulonephritis with high levels of proteinuria (  Fig. 
5 D  ), glomerular alterations (  Fig. 5 E  ), and infl  ammatory cell 
infi  ltrates into the kidneys (  Fig. 5 B  ). Kidney histology re-
vealed deposition of immune complexes in the glomeruli of 
Egr-2 cKO mice, but not WT mice (  Fig. 5 F  ). Although the 
clinical symptoms of lupuslike disease were only observed in 
mice older than 12 mo, the glomerular IgG deposits and pro-
teinuria could be detected after 8 mo (  Fig. 5 D  ). We did not 
observe a diff  erence between the two genders in susceptibility 
to disease development. To further investigate the lupuslike 
autoimmunity observed in Egr-2 cKO mice, total serum Ig 
and Ig subclass distribution was measured in WT and Egr-2 
cKO mice aged between 6 and 12 mo. Total serum Ig in Egr-2 
cKO mice was increased compared with age matched WT 
mice (  Fig. 6 A  ).   Importantly, among the Ig subclasses, only 
IgG2a was signifi  cantly increased in the sera of Egr-2 cKO 
mice (  Fig. 6 A  ), indicating a Th1-driven response. Crucially, 
both anti  –  double-stranded DNA (dsDNA) and -histone auto-
antibodies were detected in Egr-2 cKO mice (  Fig. 2 B  ). The 
titer of autoantibodies against dsDNA and histone increased 
with age and was closely associated with the accumulation of 
CD4  +  CD44  high   T cells (  Fig. 3 B  ). In Egr-2 cKO mice aged 
2  –  3 mo, both the percentage of CD44  high   T cells in the spleen 
    Figure 3.         Proliferation of T cells in Egr-2 cKO mice.   (A) Mice at 
8 mo of age were fed BrdU in drinking water for 9 d. At the end of BrdU 
treatment, splenocytes were stained with cocktails of anti-CD8, anti-
CD44, and anti-BrdU (bottom) or anti-CD4, anti-CD44, and anti-BrdU 
(top). BrdU-positive T cells were quantifi  ed after gating on CD4  + CD44 high , 
CD4CD44  low ,  CD8 + CD44 high  , or CD8  + CD44 low   cells. (B). CD4  +   or  CD8 +   T  cells 
were purifi  ed from Egr-2 cKO or WT mice at 7 mo of age and labeled with 
CFSE. The labeled cells were adoptively transferred into syngenic C57BL/6 
mice. 3 wk after transfer, splenocytes were stained with anti-CD44. Cells 
were gated on the CD44  high   or  CD44 low   population, CFSE dilution was ana-
lyzed, and the percentage of cells that had divided was quantifi  ed. Data 
are representative of three experiments.     JEM VOL. 205, September 29, 2008 
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with T cell  –  depleted splenocytes from Egr-2 cKO mice, and 
these were then adoptively transferred into Rag2       /       mice of 
the non  –  autoimmune-prone C57BL/6 background. 75 d 
after transfer, anti-dsDNA and -histone autoantibodies were 
detected in the serum of recipients given the mixture of Egr-
2  –  defi  cient CD4  +   T cells and WT non  –  T cells (  Fig. 6 C  ), but 
not in the serum of recipients of WT CD4  +   T cells mixed 
with non  –  T cells from Egr-2 cKO mice, indicating that CD4  +   
T cells deficient in Egr-2 are responsible for initiating the 
development of autoimmune disease. 
  These results demonstrate that Egr-2 intrinsically controls 
the tolerance of T cells and prevents the onset of autoimmunity. 
  Egr-2 activates p21cip1 expression in CD44  high   T cells 
  Previously, we found that p21cip1 is induced in the presence of 
Egr-2 in T cells (  9  ). There is evidence suggesting that p21cip1 
is involved in the homeostasis and self-tolerance of T cells (  17, 
18, 19  ). Intriguingly, p21cip1 KO mice also develop lupuslike 
disease (  17  ). In particular, defective p21cip1 expression may be 
partly responsible for the hyperproliferation of CD44  high   T cells 
in Egr-2 cKO mice. To investigate this possibility we examined 
the expression of p21cip1 in CD4  +  CD44  high   and CD4  +  CD44  low   
T cells of WT and Egr-2 cKO mice. We found that the CD-
44  high   population expressed approximately fi  vefold higher levels 
of p21cip1 than the CD44  low   population in WT mice (  Fig. 7 A  ).   
This pattern of p21cip1 expression correlates with that of Egr-2 
in WT mice (  Fig. 2 A  ). In contrast, the CD44  high   population 
in Egr-2 cKO mice had more than a threefold reduction in 
  expression of p21cip1 compared with WT CD44  high   cells. 
and the level of anti-dsDNA and -histone autoantibodies were 
normal. A low level of autoantibodies was detected after 
6 mo, and this increased with age, reaching a very high level 
in 12-mo-old mice (  Fig. 6 B  ), mirroring the progressive accu-
mulation of activated eff  ector T cells (  Fig. 2 B  ). Disease 
development was not infl  uenced by the Cre-transgene be-
cause anti-dsDNA and   –  histone autoantibodies were not de-
tected in aged hCD2-Cre transgenic mice, and hCD2-Cre 
transgenic mice as old as 20 mo displayed a normal phenotype 
(unpublished data). Thus, Egr-2 defi  ciency in T cells in mice 
of the non  –  lupus-prone C57BL/6 background leads to the 
loss of self-tolerance and development of an autoimmune dis-
ease similar in many respects to human lupus. 
  The autoimmunity in Egr-2 cKO is T cell dependent 
  Egr-2 is expressed in activated B cells. We found that the ex-
pression of Egr-2 could still be detected in B cells from Egr-2 
cKO mice after cross-linking of surface Ig (Fig. S1), suggesting 
that the weak activity of the CD2 promoter in B cells could 
not eff  ectively delete Egr-2 (  13  ). The failure to delete Egr-2 in 
B cells in Egr-2 cKO mice may be the reason for the normal 
B cell population and minimal B cell infi  ltration in infl  amed 
tissues (  Fig. 5 C  , Fig. S1, and Fig. S3), suggesting that T cells 
are the driving force for the development of autoimmune dis-
ease in Egr-2 cKO. 
  To determine whether the CD4  +   T cells in Egr-2 cKO 
could drive the production of autoantibodies, Egr-2  –  defi  cient 
CD4  +   T cells were mixed with T cell  –  depleted splenocytes 
from syngenic WT mice, and WT CD4  +   T cells were mixed 
    Figure 4.         Proliferation and activation of T cells in Egr-2 cKO mice.   (A) Spleen size in 15-mo-old Egr-2 cKO and WT mice, and total number of 
CD4  +   and CD8  +   T cells in spleens from these mice; presented as mean   ±   SD. (B) Isolated CD4  +   or  CD8 +   T cells from spleens of Egr-2 cKO and WT mice were 
stained for surface markers, as indicated. Bar, 5 mm.     2300 EGR-2 CONTROLS THE SELF-TOLERANCE OF T CELLS   | Zhu et al. 
promoter (  Fig. 7 B  ). The p21cip1 promoter contains a 
GAGGGGGCG site with G residues at the 1, 3, 6, 7, and 9 
positions that were shown to be important contacts in the 
crystal structure of DNA-bound Egr-1 (  10  ), which is the 
closest homologue to Egr-2 in terms of primary structure. 
To determine whether Egr-2 binds to this potential site, 
nuclear proteins were extracted from unstimulated and anti-
CD3  –  stimulated MF2.2D9 T cells. Egr-2 was detected only 
The expression of p27kip1 was also analyzed, and a similar level 
of expression was detected in CD44  high   cells from both WT and 
Egr-2 cKO mice (unpublished data). 
  To investigate whether Egr-2 can directly regulate 
p21cip1 expression we analyzed the 10-kb immediately up-
stream of the mouse p21cip1 transcriptional start site, a potential 
Egr-2 binding site (  20  ) was identifi  ed within a highly con-
served regulatory region of the mouse p21cip1 (     56 to      48) 
    Figure 5.         Development of lupuslike autoimmunity in older Egr-2 cKO mice.   (A) Skin lesions in 15-mo-old Egr-2 cKO mice compared with age-
matched WT mice. (B) Photomicrographs of spleen, liver, and kidney tissues from these mice (  ×  10) stained with hematoxylin-eosin (H-E). Note the expan-
sion of white pulp in spleens and infl  ammatory infi  ltrates around the blood vessels of liver and kidney of Egr-2 cKO but not WT. (C) Tissue sections of 
kidney from Egr-2 cKO mice were stained with antibodies against CD3 (red) and B220 (green). The sections were counterstained with DAPI for nuclear 
staining. (D) Proteinuria in age-matched WT and Egr-2 cKO mice. Data are the mean   ±   SD of values from 10 mice/group. (E) Glomeruli of a 15-mo-old 
Egr-2 cKO mouse (top) and an aged-matched WT mouse (bottom). The arrows indicate typical nuclear fragments. (F) Immune complex deposition in glo-
meruli of 15-mo-old Egr-2 cKO (left), but not in age-matched WT mice (right) as detected by fl  uorescently labeled anti  –  mouse Ig (red). The glomeruli 
were visualized by DAPI counterstaining in F. Bars: (A) 1 cm; (B) 100   μ  m; (C) 50   μ  m; (E) 25   μ  m; (F) 20   μ  m.     JEM VOL. 205, September 29, 2008 
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proximal regions of the mouse p21cip1 promoter in Egr-2  –
  expressing MF2.2D9 T cells in vivo, a chromatin immuno-
precipitation (ChIP) assay was performed using MF2.2D9 T 
cells transduced with Egr-2 or GFP control retrovirus. The 
results showed that the p21cip1 promoter was detected in 
the Egr-2 precipitates by PCR, whereas no signal above 
background was seen with irrelevant IgG or with primers 
specifi  c for the SOCS3 gene as controls (  Fig. 7 D  ), indicating 
that Egr-2 directly binds to the p21cip1 promoter in T cells. 
after TCR stimulation of MF2.2D9 cells. Nuclear proteins 
derived from TCR-stimulated, but not unstimulated, MF2.2D9 
cells bound to an oligonucleotide corresponding to this site 
and the specifi  c interaction was confi  rmed by a supershift 
induced by anti  –  Egr-2 antibody, but not Egr-3 antibody 
(  Fig. 7 C  ). The slow migration of oligonucleotide  –  Egr-2 
complexes suggests that Egr-2 may complex with additional 
factors. To assess whether Egr-2 protein associates with the 
    Figure 6.         Development of autoantibodies in Egr-2 cKO mice.  All 
the antibodies were measured by ELISA and presented either as milligram/
milliliter or absorbance (OD). (A) Serum concentration of total Ig and Ig 
isotypes. Data represent the mean   ±   SD,   n   = 24 aged 6  –  12 mo. (B) Serum 
concentration of IgG antibodies against dsDNA and histone in age 
matched Egr-2 cKO and WT mice (  n   = 6/group). (C) Serum concentration 
of IgG antibodies against dsDNA and histone from RAG 2      /      mice  that 
were recipients of T cells from Egr-2 cKO and T cell  –  depleted splenocytes 
from WT mice or T cells from WT and T cell  –  depleted splenocytes from 
Egr-2 cKO (  n   = 5 mice/group). 
    Figure 7.         Egr-2 directly activates p21cip1 expression in CD44  high   T 
cells.   (A)  CD4 + CD25      CD44 low   and  CD4 + CD25      CD44 high   T cells from WT 
and Egr-2 cKO mice were isolated by FACS sorting. The expression of 
p21cip1 was quantifi  ed by real-time RT-PCR. The relative expression of 
p21cip1 mRNA was normalized against      -actin mRNA. The data shown 
are representative of three experiments. (B) Identifi  cation of an Egr-2 
binding site in the promoter region of the p21cip1 gene. (C) Electropho-
retic mobility-shift assay to evaluate the binding of Egr-2 to oligo-
nucleotides corresponding to this sequence from the p21cip1 promoter. 
Nuclear extracts from stimulated and unstimulated MF2.2D9 cells were 
incubated with radiolabeled oligonucleotides, and complexes were re-
solved by native gel electrophoresis. Supershift was observed with anti-
Egr-2 antibody, but not with anti-Egr-3 antibody. (D) Chromatin 
immunoprecipitation assay. GFP and Egr-2  –  expressing MF2.2D9 T cells 
were cross-linked with formaldehyde and chromatin immunoprecipitated 
with anti-Egr-2 or irrelevant control antibody. The p21 promoter, but not 
the SOCS3 CDS, was detected in the immunoprecipitates by semiquantita-
tive PCR. Amplifi  cation was in the linear range. 2302 EGR-2 CONTROLS THE SELF-TOLERANCE OF T CELLS   | Zhu et al. 
Together with the defective expression of p21cip1 in CD44  high   
T cells from Egr-2 cKO mice, these data suggest that Egr-
2 directly activates the expression of p21cip1 in CD44  high   
T cells. 
  T cell differentiation in Egr-2 cKO mice 
  Although p21cip1 defi  ciency could explain the proliferative 
disorder of eff  ector T cells, there may be other mechanisms 
involved in systemic infl  ammation. To examine the role of 
Egr-2 in regulation of eff  ector T cell function, we assessed the 
expression of cytokines, including IL-2, IFN-     , IL-4, and IL-
17, in Egr-2  –  defi  cient and WT CD4 T cells after TCR liga-
tion. These cytokines are signatures for T cell activation, Th1, 
Th2, and Th17 diff  erentiation, respectively. CD4  +   T cells 
were isolated from spleens of 3-mo-old mice to avoid compli-
cations from the increased percentage of CD44  high   T cells in 
older Egr-2 cKO mice. Consistent with the normal primary 
responses in vitro (  Fig. 1 B  ), IL-2 was up-regulated normally 
in Egr-2 cKO cells (  Fig. 8 A  ). However, the expression of 
IFN-     , IL-17A, and IL-17F in Egr-2  –  defi  cient T cells was 
much higher than WT (  Fig. 8 A  ). Although IFN-      was in-
creased approximately twofold in Egr-2  –  defi  cient T cells, the 
increase in IL-17 was most signifi  cant with a four- to fi  vefold 
increase compared with WT. Interestingly, IL-4 was reduced 
in Egr-2  –  defi  cient CD4  +   T cells (  Fig. 8 A  ). To investigate the 
relevance of proinfl  ammatory cytokines to the development 
of autoimmune disease, IFN-       –   and IL-17  –  producing T cells, 
which are the hallmarks of Th1 and Th17, respectively, were 
analyzed in CD4  +   T cells from diff  erent ages. In WT mice, 
the percentage of IFN-       –  producing cells (    1.5  –  2%) was sim-
ilar in 3- and 8-mo-old mice, whereas IL-17  –  producing cells 
could barely be detected at either age (  Fig. 8 B  ).   However, a 
low level of IL-17  –  producing cells (    1.9%) were detected in 
WT T cells from mice aged 12 mo, and IFN-       –  producing 
cells were also increased to     4.5% in these mice (  Fig. 8 B  ). In 
contrast, a low level of IL-17  –   (    1.5%) and IFN-       –  produc-
ing (    5%) T cells could already be detected in T cells from 
young (3-mo-old) Egr-2 cKO mice, and the percentage of 
cells producing IL-17 and IFN-      progressively increased as 
the mice aged (IL-17,     5% at 8 mo and     9% at 12 mo; IFN-     , 
    10% at 8 mo and     13% at 12 mo;   Fig. 8 B  ). 
  We have shown that Egr-2 defi  ciency leads to the accu-
mulation of CD44  high   T cells. To determine whether the ex-
panded CD44  high   T cells in Egr-2 cKO mice are functionally 
altered, the function of CD4  +  CD44  high   T cells in WT and 
Egr-2-cKO mice at 8 mo of age was assessed by measuring the 
proportion of IFN-       –  , IL-2  –  , IL-4  –  , and IL-17  –  producing 
cells. More than 14 and 7% of CD4  +  CD44  high   cells from Egr-2 
cKO mice produced IFN-      and IL-17, respectively, com-
pared with   <  4 and   <  2% of CD4  +  CD44  high   cells in WT mice 
(  Fig. 8 C  ). In contrast,   <  2 and  <  0.5% of CD4  +  CD44  low   cells 
produced IFN-      and IL-17, respectively, in either Egr-2 cKO 
    Figure 8.         Cytokine expression and T cell differentiation of Egr-2  –
  defi  cient CD4  +   T cells.   (A)  CD4 +   T cells from 3-mo-old WT and Egr-2 
cKO mice were stimulated without (-) or with anti-CD3 (+) for 6 h and 
cytokine expression was quantifi  ed by real-time RT-PCR. The relative ex-
pression of cytokines was normalized to      -actin mRNA. The results are 
representative of three experiments. (B) CD4  +   T cells from WT and Egr-2 
cKO mice of different ages indicated were stimulated for 5 h with PMA 
and ionomycin before staining with IFN-      and IL-17. (C) CD4  +   T  cells 
from 8-mo-old mice were stimulated for 5 h with PMA and ionomycin 
and then stained with CD44, IFN-     , and IL-17. The cytokine-positive cells 
were quantifi  ed after gating for CD44  low   or  CD44 high  . (D) Splenocytes from 
8-mo-old mice were stimulated for 5 h with PMA and ionomycin and 
then stained with CD4, CD44, and the indicated cytokine antibodies. Cyto-
kine-positive CD44  high   cells were quantifi  ed after gating for CD4  +   cells.   
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  autoimmune diseases. The accumulation of IFN-       –   and IL-17  –
  producing CD4  +   T cells in Egr-2 cKO mice suggests the pos-
sibility that the activated CD4  +   T cells are eff  ector infl  ammatory 
T cells primed by self-antigen, and that the loss of tolerance 
in Egr-2 cKO mice leads to the expansion of these cells and 
autoimmune responses. 
  We found that the cell cycle inhibitor p21cip1 is a direct 
target gene of Egr-2. Egr-2 defi  ciency results in defective ex-
pression of p21cip1 in CD44  high   T cells. Most of the reports 
from p21cip1       /       mice have shown enhanced T cell activation, 
proliferation, and autoimmune manifestations (  17, 18, 19  ), 
which are largely consistent with Egr-2 cKO mice. However, 
a study in the BXSB atypical lupus model showed that p21cip1 
deletion increased apoptosis of activated T cells and decreased 
disease incidence in male mice suggesting that p21cip1 regu-
lates proliferative responses by blocking apoptosis (  24  ). How-
ever, the increased apoptosis in response to TCR stimulation 
suggests a diff  erential eff  ect of p21cip1 in the activation and 
proliferative responses of T cells. In a recent study in C57BL/6 
mice, p21cip1 deletion only enhanced T cell proliferation at 
a late stage of stimulation (  19  ), which is consistent with our 
fi  ndings in Egr-2 cKO mice of C57BL/6 background. Col-
lectively, these studies indicate that p21cip1 is involved in the 
regulation of eff  ector T cell proliferation, but plays only a part 
of the tolerance program, and its function in lupus develop-
ment is dependent on the genetic predisposition. Indeed, in 
addition to the altered expression of p21cip1, enhanced diff  er-
entiation of Th1 and Th17 cells in Egr-2 cKO mice was found. 
Although we do not yet know how Egr-2 regulates the ex-
pression of proinfl  ammatory cytokines, the accumulation of 
Th1 and Th17 cells can directly result in infi  ltration of T 
cells into multiple organs and infl  ammatory autoimmune dis-
eases (  25  ). These results have not been reported in p21cip1-
defi  cient mice (  17  ). 
  The increased expression of IFN-      and IL-17 in Egr-2  –
  defi  cient T cells after TCR ligation suggests that Egr-2 may 
be involved in the control of infl  ammatory cytokines in eff  ec-
tor T cells. Such control may not only be important to pre-
vent infl  ammatory reactions of autoreactive T cells but also 
for the reduction of immunopathology during a productive 
immune response. Although both Th1 and Th17 are observed 
in most autoimmune models, the mechanisms mediating Th1 
and Th17 diff  erentiation in vitro are distinct (  25  ), whereas the 
in vivo mechanisms are still unknown. NFAT has been found 
to induce IFN-      expression and activate the IL-17 promoter 
(  26, 27  ). Egr-2 is one of the NFAT target genes in T cells. 
Therefore, the expression of Egr-2 could act as negative feed-
back loop to control IFN-      and IL-17 expression in response 
to TCR stimulation. Although we did not fi  nd altered activa-
tion of NFAT in Egr-2  –  defi  cient T cells from aged mice (un-
published data), the possibility that Egr-2 physically interacts 
with NFAT and inhibits its activity has yet to be analyzed. 
The reduced production of Th2 cytokines could either result 
from enhanced Th1 and Th17 diff  erentiation or direct reg-
ulation by Egr-2; future investigations will further examine 
these hypotheses. 
or WT mice (  Fig. 8 C  ). However, the percentage of IL-4  –  pro-
ducing cells was reduced in Egr-2  –  defi  cient T cells (  Fig. 8 D  ). 
Thus, the large population of CD4  +  CD44  high   T cells in Egr-2 
cKO mice are predominately Th1 or Th17 type eff  ector T cells. 
Importantly, the percentage of IL-2  –  producing T cells was 
very similar in Egr-2 cKO and WT mice (  Fig. 8 D  ), indicating 
that the expansion of CD44  high   T cells in Egr-2 cKO is not 
caused by enhanced IL-2 expression. These results suggest that 
hyperproliferation of eff  ector T cells and Th1 and Th17 dif-
ferentiation are the major disorders in Egr-2 cKO mice. 
  To investigate the mechanisms behind the increased ex-
pression of IFN-      and IL-17, we examined the expression of 
T-bet, a Th1 transcription factor, and IL-6, -21, and -23, 
which can induce Th17 diff  erentiation in CD4  +   T cells from 
aged Egr-2 cKO mice. The expression of these molecules 
was not altered (unpublished data), suggesting that Egr-2 may 
be directly involved in regulation of IFN-      and IL-17 ex-
pression or Th1 and Th17 diff  erentiation. 
    DISCUSSION   
  In this study, we have discovered that Egr-2 controls the pro-
liferation and tolerance of T cells. Loss of Egr-2 expression 
leads to the accumulation of CD44  high   T cells, enhanced ex-
pression of proinflammatory cytokines, increased Th1 and 
Th17 diff  erentiation, and development of a late onset lupus-
like autoimmune disease. 
  We and others have previously found that Egr-2 is induced 
in tolerant T cells after TCR stimulation (  7, 8, 9  ). We have 
now found that Egr-2 is normally expressed in CD44  high   T 
cells, and that Egr-2 defi  ciency results in a massive accumula-
tion of these cells. CD44  high   is a marker for eff  ector or memory 
T cells (  2  ). The CD44  high   T cells in WT mice raised in a clean 
environment are presumably generated in response to com-
mensal antigens, gut fl  ora, or self-antigen (  2  ). In contrast to the 
resting CD44  low   naive T cells, CD44  high   cells undergo slow and 
intermittent proliferation in response to homeostatic stimuli 
such as self-antigen and cytokines (  2  ), and also it has been 
found that CD44  high   memory T cells are intrinsically more sen-
sitive than CD44  low   naive cells to stimulation through the 
TCR  –  CD8 complex (  21  ). The expression of Egr-2 in CD44  high   
cells may be induced from homeostatic responses to serve 
as a feedback mechanism to control the proliferation and acti-
vation of CD44  high   T cells. The development of systemic auto-
immune responses in Egr-2 cKO mice demonstrates the 
importance of such controls. 
  Several fi  ndings in predisposed mice appear to support the 
notion that primary or secondary homeostatic lymphocyte 
perturbations, such as in MRL/lpr and p21cip1 KO mice of 
C57BL/6 background, contribute to the pathogenesis of 
spontaneous lupus (  17, 22, 23  ). These fi  ndings suggest that 
uncontrolled T cell proliferation can lead to T cell expansion 
and generation of eff  ector cells to self-antigens, resulting in 
the development of lupuslike systemic autoimmune diseases. 
Our results indicate that Egr-2 is an intrinsic regulator that 
controls not only proliferation but also infl  ammation of eff  ec-
tor T cells, and also inhibits the development of lupuslike 2304 EGR-2 CONTROLS THE SELF-TOLERANCE OF T CELLS   | Zhu et al. 
  Peripheral T cells are tolerant to self-antigens, which is 
achieved by limiting the expansion and activation of self-reac-
tive T cells (  1  ). In addition to the function of regulatory T 
cells (  5  ), several intrinsic mechanisms have been discovered 
that either induce T cell anergy or limit T cell expansion (  4  ), 
such as the GRAIL E3 ligase, which is induced in anergic T 
cells and inhibits IL-2 expression by targeting TCR signaling 
molecules (  30  ). In addition, control of T cell growth and reg-
ulation of apoptosis are also important mechanisms to main-
tain self-tolerance (  1  ). Egr-2 has been found to regulate 
expression of an E3 ligase (  8  ), and now we show that Egr-2 
directly activates p21cip1 expression in CD44  high   T cells and is 
involved in the control of Th1 and Th17 diff  erentiation. Our 
data demonstrate that Egr-2 is an intrinsic regulator of eff  ector 
T cells and is essential for the control of their proliferation and 
infl  ammatory activation in the absence of overt antigen stimu-
lation. The fact that Egr-2 is expressed in eff  ector, but not in 
naive T cells, and controls their proliferation in vivo without 
interfering with their responses to optimal TCR stimulation 
provides insight into how the threshold for T cell activation is 
regulated, thus enabling the activation and expansion of eff  ec-
tor T cells only in response to optimal antigen stimulation and 
limiting the expansion of hypersensitive or potentially auto-
reactive cells. The development of systemic autoimmune disease 
in Egr-2 cKO mice with characteristics of human lupus makes 
this a good model for further studies into the mechanisms of 
lupus development and could potentially yield novel thera-
peutic strategies. 
    MATERIALS AND METHODS   
  Generation of conditional Egr-2 knock-out mice.    Egr-2 cKO mice were 
generated by crossing fl  oxed Egr-2 mice (obtained from P. Charnay, Institut Na-
tional de la Sant  é   et de la Recherche M  é  dicale, Paris, France) (  14  ) with hCD2-
Cre transgenic mice in which Cre-induced recombination is detected only in 
T and B cells (  13  ). The primer pairs (p1, 5     -agttgacagcccgagtccagtgg-3     ; p2, 
5     -gggagcgaagctactcggatacgg-3     ; sense 5     -CCAACAACTACCTGTTCT-
GCCG-3     ; antisense 5     -TCATCCTTGGCACCATAGATCAGG-3     ) were 
used for genotyping of Egr-2-Loxp and iCre loci, respectively. The Egr-2 
fl  oxed mice are used as a control. Rag2       /       mice have been described before 
(  13  ). All mice used in this study are on the C57BL/6 background or have 
been backcrossed at least three times to C57BL/6. All mice were maintained 
in the Biological Services Unit, Barts and The London School of Medicine, 
and used according to established institutional guidelines under the authority 
of a UK Home Offi   ce project license (Guidance on the Operation of Animals, 
Scientifi  c Procedures Act 1986). UK home offi   ce approved our animal project 
license for this experiment. 
  Antibodies.     FITC-conjugated antibodies to CD4 and CD62L; PE-conjugated 
antibodies to CD4, CD8, NK1.1, F4/80, CD25, and CD69; allophycocyanin 
(APC)-conjugated antibodies to CD44 and Annexin V; peridinin chlorophyll 
protein (PerCP)  –  conjugated antibody to CD3, PE-labeled anti-p-stat5, rat 
anti  –  mouse B220 antibody for immunohistochemistry, and antibody to CD3 
(clone 145-2C11) and CD28 (clone 37.51) for stimulation were obtained from 
BD Biosciences. FITC-conjugated antibody to IFN-     , PE-conjugated anti-
bodies to IL-4, IL-2, and Foxp3 were bought from eBioscience. Rabbit anti  –
  human CD3 antibody for immunohistochemistry was purchased from DAKO. 
FITC-conjugated donkey anti  –  rat IgG and Alexa Fluor 594  –  conjugated don-
key anti  –  rabbit IgG second antibodies were obtained from Jackson Immuno-
research Laboratories. Egr-2 antibody was purchased from Covance. 
  Both Egr-2 and -3 are expressed in double-negative thy-
mocytes, and defective expression of Egr-3 leads to the accu-
mulation of double-negative thymocytes and reduction of 
DP thymocytes in the thymus (  12  ), indicating that Egr-3 is 
involved in thymocyte development before thymocyte selec-
tion. However, we did not fi  nd a similar phenotype in the 
thymus of Egr-2 cKO mice, suggesting that either Egr-2 
function at this stage is redundant or that Cre-mediated dele-
tion was incomplete at this stage. T cell lines overexpressing 
Egr-2 or -3 show an up-regulation of Cbl-b and reduced 
production of IL-2 (  7, 8  ). This fi  nding led to the hypothesis 
that the mechanism for Egr-2 in maintaining T cell tolerance 
would be down-regulation of TCR signaling. However, we 
could not detect diff   erences between Egr-2  –  defi  cient  and 
WT naive T cells in the major TCR signaling pathways, such 
as AP1, NF-     B, NFAT, and MAP kinase, after TCR stimu-
lation in vitro (Fig. S4 and not depicted). In addition, we did 
not observe hyperproliferation of naive Egr-2 cKO T cells in 
response to primary TCR stimulation. This normal response 
to TCR engagement could be caused by functional compen-
sation by Egr-3 (  8  ). Nevertheless, the continuously prolifer-
ating T cell lines (  7, 8  ) and preactivated primary T cells (  8  ) 
used in these studies share some features of the hyperactive 
CD44  high   T cells in Egr-2 cKO mice. Therefore, the negative 
regulation of T cell activation in these reports is consistent 
with the hyperproliferation and activation of Egr-2  –  defi  cient 
T cells in vivo. 
  Egr-2 has been found to induce FasL expression in T cells 
(  15, 16  ). Defi  ciency in Fas expression in MRL/lpr mice re-
sults in severe lupuslike disease caused by the resistance of 
T cells to apoptosis (  22, 23  ). However, Egr-2 defi  ciency did 
not alter expression of FasL in T cells or apoptosis in either 
young or old mice, and CD3  +  CD4        CD8         T cells were not 
detected in spleen of old Egr-2 cKO mice (Fig. S5), suggest-
ing distinct mechanisms for lupuslike disease in Egr-2 cKO 
and MRL/lpr mice. Recently, reduced expression of Egr-2 
and -3 has been found in T cells from BALB/c mice after in-
duction of lupuslike disease by an anti-DNA antibody, and 
the decreased expression was associated with increased IFN-      
secretion (  28  ), suggesting that Egr molecules are involved in 
the maintenance of self-tolerance. 
  Although antinuclear antibodies are hallmarks of sys-
temic lupus, the mechanisms responsible for the breakdown 
of self-tolerance are still unknown. One of the character-
istics of the autoimmune disorder in lupus patients is 
Th1-mediated inflammation with a high level of IFN-      
production and increased serum IgG2a antibody (  22  ), both 
of which we have observed in aged Egr-2 cKO mice. In ad-
dition, a massive increase in IL-17 production in activated T 
cells and an increased percentage of Th17 cells in Egr-2 
cKO mice were observed. Th17 plays an important role in 
the development of lupuslike disease (  29  ). These results sug-
gest that autoimmune disorders can result from a loss of 
control of eff  ector T cell expansion and infl  ammatory acti-
vation, and that this control is mediated by genes regulated 
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and protease and phosphatase inhibitors (Roche), and the aliquots were fro-
zen at      80  °  C. Protein concentration was determined using the BCA method 
(Sigma-Aldrich) according to the manufacturer  ’  s instructions. Immunoblotting 
was performed as in our previous study (  9  ). 
  EMSA.     EMSA was performed as previously described (  31  ). In brief, the p21 
probe (5     -GGGCTGCCTCTGAGGGGGCGGGGC-3     ) was labeled with 
[     -  32  P]dCTP using Ready-to-Go DNA labeling beads (GE Healthcare) ac-
cording to the manufacturer  ’  s instructions. This was then purifi  ed using Probe-
Quant G-50 microcolumns (GE Healthcare), and binding reactions were 
performed with nuclear extracts from stimulated and unstimulated MF2.2D9 
cells in 10 mM Hepes, pH 7.5, 50 mM KCl, 2.5 mM MgCl  2 , 10 mM DTT, 
1   μ  g poly(dI-dC), 10% glycerol, 0.5 mM ZnCl  2 , and 5 mM spermidine. The 
reactions were incubated at room temperature for 40 min with double-stranded 
  32  P-labeled oligonucleotide. For supershift reactions, anti-Egr-2 and anti-Egr-3 
antibody were added after 10 min of incubation. The samples were electro-
phoresed on 5% polyacrylamide gels in 0.5  ×   TBE. The gels were dried under 
vacuum and exposed to autoradiographic fi  lm at   –  80  °  C. 
  Retroviral transduction.     pBabe Egr-2, provided by K. Jessen (University 
College London, London, England) was transfected into the Phoenix pack-
aging cell line using FuGene according to the manufacturer  ’  s instructions. 
Retrovirus containing supernatant was collected 48 h later. This was added 
to a RetroNectin (Takara)-coated plate and incubated at 32  °  C for 4 h. The 
plates were washed with PBS, and then MF2.2D9 murine T hybridoma 
cells, provided by K.L. Rock (University of Massachusetts Medical School, 
Worcester, MA) were added. Cells were expanded and GFP-positive cells 
were isolated by FACS. 
  ChIP.     ChIP assays were performed according to the protocol supplied by 
Millipore. 10  8   Egr-2 and GFP-transduced MF2.2D9 cells were cross-linked 
with 1% formaldehyde for 10 min at room temperature. After quenching 
of formaldehyde with 125 mM glycine, chromatin was sheared by sonica-
tion. The size of sonicated chromatin was     300  –  1,000 bp as analyzed on 
agarose gels. Fragmented chromatin (500   μ  g) was precleared for 1 h with 
salmon sperm DNA/BSA-blocked protein A beads (GE Healthcare) and 
subjected to immunoprecipitation with specifi  c anti-Egr-2 Ab (Covance) 
or control antibody at 4  °  C overnight. Immunocomplexes were recovered 
by incubation with blocked protein A beads and washed in low salt, 
and then high salt, and fi  nally LiCl buff  er. DNA was purifi  ed by phenol 
chloroform extraction and used as template for PCR with specifi  c oligo-
nucleotides p21 sense (5     -ATCGGTGAAGGAGTGGGTTGGTCC-3     ), 
p21 antisense (5     -ACACCTCTCGGCTGCTGCAGTTGG-3     ), SOCS3 
sense (5     -TGTGTACTCAAGCTGGTGCAC-3     ), and SOCS3 antisense 
(5     -CATACTGATCCAGGAACTCC-3     ). 
  Histological and serological analysis.     Tissues were fi  xed with 10% for-
malin in PBS and embedded in paraffi   n. Sections were stained with hema-
toxylin and eosin by standard methods. Histological examination of kidneys 
was done in a blind manner. Proteinuria was determined using reagent strips 
for urinalysis, URS-5K (Access Diagnostics Tests). For immunohistochem-
istry, kidney sections were stained with rabbit anti  –  human CD3 and rat 
anti  –  mouse B220. After washing, sections were further stained with Alexa 
Fluor 594  –  conjugated donkey anti  –  rabbit IgG and FITC-conjugated don-
key anti  –  rat IgG secondary antibodies, followed by counterstaining with 
DAPI. For analysis of Ig deposits, 6   μ  m frozen kidney sections were pro-
cessed as previously described (  32  ) and stained with a Texas red  –  conjugated 
donkey anti  –  mouse IgG (Jackson ImmunoResearch Laboratory). Total se-
rum IgG and Ig isotypes were captured with goat anti  –  mouse Ig, and con-
centrations were determined by ELISA with HRP-conjugated antibodies 
against IgG, IgG1, IgG2a, IgG2b, and IgM (Sigma-Aldrich). Reactivity of 
these antibodies was normalized for equivalent OD against total IgG and the 
corresponding isotype controls (Sigma-Aldrich). 
  The levels of anti-histone and anti-dsDNA antibodies in serum were 
measured according to published methods (  33  ). In brief, 5   μ  g/ml Calf 
  Cell isolation and stimulation.     Primary CD4  +   T cells were purifi  ed by 
positive selection using a MACS system (Miltenyi Biotec), with purity con-
sistently   >  90%. The CD4  +  CD44  high   and CD4  +  CD44  low   T cells were sorted 
by FACS after staining with FITC-conjugated CD4, PE-conjugated CD44, 
and APC-conjugated CD25 antibodies (eBioscience). Cells were gated on 
CD25        cells to exclude activated cells and regulatory T cells. T cells were 
cultured in RPMI 1640 medium supplemented with 10% FBS, 50   μ  M 
2-ME, and 100 U/ml penicillin and 100   μ  g/ml streptomycin. Purifi  ed CD4  +   
T cells were stimulated with 1   μ  g/ml CD3 and 1   μ  g/ml CD28 antibody-
coated beads, uncoated beads, or IL-2 as indicated. 
  Proliferation.     To measure proliferation, purifi  ed CD4  +   T cells (5   ×   10  4   
cells/200   μ  l) in 96-well plates were stimulated in triplicate. A total of 1   μ  Ci 
of [  3  H]TdR was added for the last 8 h of culture, and cells were harvested 
and subjected to scintillation counting to measure [  3  H]TdR incorporation. 
To analyze the in vivo proliferation of T cells mice were fed with 0.8 mg/ml 
BrdU in drinking water for 9 d. The splenocytes were stained with PE-con-
jugated anti-CD4 or -CD8 antibody and APC-conjugated CD44 antibody, 
followed by staining with FITC-conjugated anti-BrdU antibody with the 
BrdU fl  ow kit (BD Biosciences). The percentage of T cells that had incor-
porated BrdU was analyzed by FACS. The proliferation of adoptively trans-
ferred CD4  +   or CD8  +   T cells in WT C57BL/6 mice was analyzed by CFSE 
labeling. Purifi  ed CD4  +   or CD8  +   T cells from Egr-2 cKO or WT mice were 
labeled with CFSE and transferred into syngeneic 12-wk-old C57BL/6 
mice. 3  –  4 wk later, CD4  +   or CD8  +   T cells were purifi  ed from the spleens 
of recipients and stained with PE-anti-CD44 antibody before analysis of 
CFSE staining. 
  Intracellular cytokine analysis.     Splenocytes or CD4  +   T cells harvested 
from mice of diff  erent ages were stimulated with 20 ng/ml PMA plus 0.5 
  μ  g/ml ionomycin in the presence of Brefeldin A for 5 h. Cells were then 
stained for cell surface markers (CD4 and CD44), and intracellular cytokine 
staining was performed with the Fixation and Permeabilization kit and IFN-     , 
IL-2, IL-4, and IL-17 antibodies in accordance with the manufacturer  ’  s in-
structions (eBioscience). 
  Quantitative real-time PCR.     Real-time PCR was performed as previ-
ously described (  31  ). In brief, total RNA was extracted from CD4  +   T cells 
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thymus DNA or histones (Sigma-Aldrich) in PBS were coated at 0.2 ml/
well in Immulon II microtiter plates (Dynatech Laboratories., Inc.). After 
overnight incubation at 4  °  C, wells were postcoated with 0.4 ml gelatin (1 
mg/ml in PBS) for 2 h at 37  °  C. After washing, 0.2 ml of serum samples di-
luted 1:1,000  –  1:4,000 in 0.1% Tween, 1 mg/ml gelatin, and 0.5% BSA in 
PBS were added and incubated for 1.5 h at room temperature. After wash-
ing, HRP-conjugated rabbit anti  –  mouse Ig (Dako) diluted 1:4,000 in 0.1% 
Tween in PBS was added. After 1.5 h of incubation at room temperature, 
the wells were washed and substrate solution was added. The OD was then 
read with an automated spectrophotometer at 492 nm. 
  Adoptive transfer.     T cell  –  depleted splenocytes were prepared from Egr-2 
cKO and WT mice aged 8 mo using a Pan T cell isolation kit (Miltenyi Bio-
tec), according to the manufacturer  ’  s protocol and CD4  +   T cells were iso-
lated by positive selection with CD4 (L3T4) microbeads (Miltenyi Biotec). 
10  6   CD4  +   T cells from Egr-2 cKO mice were mixed with 1.5   ×   10  6   T cell  –
  depleted splenocytes from WT mice or 10  6   CD4  +   T cells from WT mice 
were added to 1.5   ×   10  6   T cell  –  depleted splenocytes from Egr-2 cKO mice. 
These mixtures were suspended in 100   μ  l of physiological saline and injected 
i.v. into the dorsal tail vein of female Rag2       /       mice at 12 wk of age. 75 d 
after transfer, serum antibodies against dsDNA and histones were measured. 
  Statistics.     The Mann-Whitney   U   test was used. The normality of data dis-
tribution and the homogeneity of variances of the data were verifi  ed by the 
K-S Lilliefors and Cochran C tests, respectively. 
  Online supplemental material.     Fig. S1 shows the results of genotyping of 
Egr-2 cKO mice and Egr-2 expression in B and T cells. Fig. S2 shows 
development of thymocytes in Egr-2 cKO mice comparing to WT mice. 
Fig. S3 shows the subgroups of lymphocytes in spleens of WT and Egr-2 
mice. Fig. S4 shows ERK and STAT5 activation in T cells after TCR liga-
tion. Fig. S5 shows the results of apoptosis analysis of CD4 T cells. Fig. S6 
displays percentage of NK, macrophage, and B cells in spleens of WT and 
Egr-2 cKO mice. The online supplemental material is available at http://
www.jem.org. The online version of this article is available at http://www
.jem.org/cgi/content/full/jem.20080187/DC1. 
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